Allegra-D

暂无该语言内容。

• 2026
  [5]FDA current Approved Drug Product List, June 2026fda.gov
• 2025
  [9]Opella becomes independent in 2025opella.com
• 2020
  [14]Allegra-D “Say Yes” advertising recordispot.tv
• 2015
  [4]FDA 2021 correspondence concerning Allegra-D labeling and pediatric requirementsfda.gov
• 2005
  [12]Sanofi announcement of Allegra-D 24 Hour availabilitynews.sanofi.us
• 2004
  [11]Allegra-D 24 Hour FDA approval historydrugs.com
• 1997
  [3]FDA environmental assessment for original Allegra-Daccessdata.fda.gov
• 1996
  [13]Allegra-D trademark recordtrademarks.justia.com

• 1997

  Allegra-D 12 Hour Allergy & Congestion

• 2004

  Allegra-D 24 Hour Allergy & Congestion

• 2020Say Yes

  United States

  来源

• 2025

  并购

  Ownership of Opella. Opella was controlled by Sanofi → CD&R 50.0% controlling stake; Sanofi 48.2%; Bpifrance 1.8% (April 30, 2025)

  来源

• 2015

  其他

  来源

• 2004

  换代

  来源

• 1997

  新品

  来源

1. 1Allegra official U.S. product portfolioallegra.com
2. 2Allegra-D 24 Hour official product informationallegra.com
3. 3FDA environmental assessment for original Allegra-Daccessdata.fda.gov
4. 4FDA 2021 correspondence concerning Allegra-D labeling and pediatric requirementsfda.gov
5. 5FDA current Approved Drug Product List, June 2026fda.gov
6. 6DailyMed Allegra-D 12 Hour labelingdailymed.nlm.nih.gov
7. 7DailyMed Allegra-D 24 Hour labelingdailymed.nlm.nih.gov
8. 8Opella leadershipopella.com
9. 9Opella becomes independent in 2025opella.com
10. 10Sanofi and CD&R close Opella transactionsanofi.com
11. 11Allegra-D 24 Hour FDA approval historydrugs.com
12. 12Sanofi announcement of Allegra-D 24 Hour availabilitynews.sanofi.us
13. 13Allegra-D trademark recordtrademarks.justia.com
14. 14Allegra-D “Say Yes” advertising recordispot.tv